Related Experiment Video
Updated: Jan 15, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
The potential interest of topiramate in addiction
Gabriel Thorens1, Joel Billieux, Rita Manghi
1Division of Addictology, University Hospitals of Geneva, Switzerland. Gabriel.Thorens@hcuge.ch
Abstract:
Topiramate is one of the currently most promising compounds in the field of addiction medicine. This paper discusses its potential utility related to a phase model of addiction development, focusing on the assumption that addiction is a continuous process involving different neurobiological pathways, depending on the stage of addiction. A specific emphasis will be made on the development of dysfunctional automatic behaviors in late stage of addiction and the central role of glutamate and AMPA receptors. The aim is to propose that if a too broad effect of anti-addiction medication is expected (such as anti-craving, anti-relapse and preventive effects), the results might be disappointing. The speculative specific efficacy of topiramate in addiction is described.
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Antiepileptic Drugs: Glutamate Antagonists
Drug Dependence
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Analgesia and Pain Management
Psychosis: Goals of Pharmacotherapy

